Tissue Blood Articles & Analysis

The Indiana University Philanthropic Venture Fund, which provides capital to faculty, students, alumni and staff at all IU campuses to help them further develop their research and innovations into startup companies, has invested in Vascuqen Inc., a regenerative medicine company. Vascugen is focused on finding therapies to repair human tissue damaged by reduced blood flow due to disease or ...

By Vascugen Inc.

OnLume Inc., an early stage medical imaging company with unique technology for improving surgical precision, has been awarded a substantial grant from the U.S. National Institutes of Health (NIH)’s National Cancer Institute (NCI) to advance development of its proprietary device for Fluorescence-Guided Surgery (FGS). OnLume has developed novel FGS imaging technology to illuminate critical ...

By OnLume Inc.

There is no doubt that 2-dimensional (2D) ultrasound imaging can be a challenging task to learn. Performing ultrasound requires some imagination. A simple turn of the transducer can change the orientation of anatomy. Therefore, learning anatomy in this way is not always straightforward as with 3-dimensional fixed images. To further complicate matters, the human body presents obstacles at nearly ...

By EchoNous, Inc.

The US-based chemical supplier Alfa Chemistry announced the launch of a new sub-website for the supply of functional polymers, including Adsorptive Polymers, Biomedical Polymers, Electrofunctional Polymers, Functional PEGs, Photoactive Polymers, Silicone Polymers and more. With unstopping efforts, the company continues to offer chemicals for specialized applications, such as catalysts, fatty ...

By Alfa Chemistry

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced positive financial results for the year ended December 31, 2018. Consistent with performance for the past two years, revenue continues to increase, up 21% or $1.2m for year-end, 2018 compared to 2017, from $5.5m to $6.7m. ...

By U.S. Stem Cell, Inc. (USRM)

OncoDNA, a genomic and theranostic company specializing in precision medicine, and Bergonié Institute, a non-profit private hospital entirely devoted to fighting cancer, today announced a new clinical trial to evaluate the use of comprehensive biomarker testing and liquid biopsy in 700 patients diagnosed with an advanced metastatic cancer. The Appolo study will recruit patients from 6 ...

By OncoDNA S.A.

Waltham, MA - Nova Biomedical announces the addition of another important critical care parameter to its Stat Profile Prime Plus blood gas analyzer—the ability to rapidly calculate and report mean corpuscular hemoglobin concentration (MCHC). MCHC is a measure of the hemoglobin concentration in a given volume of packed red blood cells. MCHC, along with measured hemoglobin and ...

By Nova Biomedical

Vascuqen Inc. today announced that it has licensed a suite of intellectual property developed at the Indiana University (IU) School of Medicine related to blood vessel formation from adult stem cells. The regenerative medicine company is focused on finding therapies to repair tissues damaged by reduced blood flow due to disease or injury. The worldwide, exclusive licenses include patent rights ...

By Vascugen Inc.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced that the company has signed agreements for in-network provider status with Humana Military and Health Net Federal Services, which administer the TRICARE health program for military members, retirees and their families (TRICARE).1,2 TRICARE is one of the largest health plans in the United States with 9.6 million ...

By Foundation Medicine, Inc.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and blood-based assays as companion diagnostics for RETEVMO® and other therapies in Loxo Oncology at Lilly’s pipeline. The partnership will initially explore the use of FoundationOne®CDx for adult ...

By Foundation Medicine, Inc.

A2LA is proud to announce the issuance of its first accreditation, and the first such accreditation in the world, to the newly published standard ISO 20387:2018 – Biobanking – General requirements for biobanking. ISO 20387 contains requirements designed to demonstrate the competence of a biobank’s operation and ability to provide biological material and associated data for ...

By American Association for Laboratory Accreditation (A2LA)

Offer price increased from €39.00 to €43.00 per QIAGEN share in cash Minimum acceptance threshold lowered from 75% to 66.67% of outstanding QIAGEN shares QIAGEN Supervisory and Managing Boards reaffirm unanimous recommendation that QIAGEN shareholders tender all of their QIAGEN shares Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. ...

By Thermo Fisher Scientific, LIMS & Laboratory Software

OnLume has received 510(k) clearance from the U.S. Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This ...

By OnLume Inc.

It’s been a tough but very worthwhile swimming journey for our Wales and West Contracts Manager Dave Harry who recently took part in Swimathon 2015 fundraising for Ehlers-Danlos syndrome. Dave successfully swam 5KM (3 miles) and raised £455 towards ongoing research into this condition – a huge thank you to everyone that sponsored and supported Dave along the way including his ...

By Eco Environmental Services Ltd

OnLume Surgical, a Wisconsin-based medical device company developing novel imaging systems for use during surgery, announced the completion of its Series A funding to assist its plans for commercial launch. OnLume raised over $7 Million in this financing, adding to a $2 Million Phase II SBIR grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH), awarded in ...

By OnLume Inc.

OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start of participation in a clinical trial combining its fluorescence-guided surgery (FGS) imaging device with a novel nerve-targeting agent. OnLume has unique FGS imaging technology to illuminate critical anatomy in real time during ...

By OnLume Inc.

This past November, the U.S. Food and Drug Administration (FDA) announced a Class 1 recall of the Ikaria INOmax DS Drug Delivery System. The device is a drug delivery system used with ventilators to deliver a preset concentration of INOmax therapy gas (nitric oxide for inhalation) for critically ill patients. According to the FDA posting regarding the recall, “Fretting corrosion at the ...

By EMSL Analytical, Inc.

Agilent Technologies Inc. (NYSE: A) and Expression Analysis Inc. today announced that Expression Analysis has achieved Certified Service Provider status for the Agilent SureSelect Target Enrichment System. SureSelect has been shown to greatly increase the speed and cost-efficiency of next-generation sequencing by enabling researchers to focus experiments on genomic regions of interest rather ...

By Agilent Technologies, Inc.

Pisa, Italy-September 7, 2022 - Medical Microinstruments. Inc. (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced the launch of its new Supermicro NanoWrist® instruments for use with the Symani® Surgical System, developed specifically to address the challenges of microsurgery. The new supermicro needle holder and ...

By Medical Microinstruments (MMI) S.P.A.

BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the launch of its first oncology liquid biopsy products, Northstar Select™ and Northstar Response™. The products are currently available for research use with select academic cancer centers. Northstar Select is a comprehensive ...

By BillionToOne Inc.